2021
Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data
Zimmermann L, Salvatore M, Babu G, Mukherjee B. Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data. American Journal Of Public Health 2021, 111: s59-s62. PMID: 34314196, PMCID: PMC8495647, DOI: 10.2105/ajph.2021.306419.Peer-Reviewed Original Research
2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer
Lee A, Bomkamp A, Bandera E, Jensen A, Ramus S, Goodman M, Rossing M, Modugno F, Moysich K, Chang‐Claude J, Rudolph A, Gentry‐Maharaj A, Terry K, Gayther S, Cramer D, Doherty J, Schildkraut J, Kjaer S, Ness R, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah P, Chenevix‐Trench G, Olson S, Hogdall E, Wu A, Pike M, Stram D, Pearce C, Consortium F. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal Of Cancer 2016, 139: 2646-2654. PMID: 27420401, PMCID: PMC5500237, DOI: 10.1002/ijc.30274.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedAged, 80 and overAllelesAlternative SplicingCase-Control StudiesDisease SusceptibilityEstrogen Replacement TherapyFemaleGene-Environment InteractionGenome-Wide Association StudyGenotypeHumansMenopauseMiddle AgedOdds RatioOvarian NeoplasmsPolymorphism, Single NucleotidePopulation SurveillanceRiskTelomeraseConceptsOvarian Cancer Association ConsortiumEstrogen-alone therapyOvarian cancer riskEndometrioid ovarian cancerOvarian cancerET usersET useT alleleAssociated with ovarian cancer riskCancer riskLong-term ET usersOvarian cancer susceptibility lociRisk of ovarian cancerSusceptibility variantsMenopausal estrogen therapyCancer susceptibility lociSerous ovarian cancerSplice variantsNon-usersCase-control studyConditional logistic regressionGenome-wide association studiesIncreased risk of diseaseEndometrioid histotypeEstrogen therapy
2012
Where science meets policy: comparing longitudinal and cross-sectional designs to address diarrhoeal disease burden in the developing world
Markovitz A, Goldstick J, Levy K, Cevallos W, Mukherjee B, Trostle J, Eisenberg J. Where science meets policy: comparing longitudinal and cross-sectional designs to address diarrhoeal disease burden in the developing world. International Journal Of Epidemiology 2012, 41: 504-513. PMID: 22253314, PMCID: PMC3324455, DOI: 10.1093/ije/dyr194.Peer-Reviewed Original ResearchConceptsCross-sectional studyCross-sectional designEffect estimatesLongitudinal studyRisk factorsDisease risk factorsRisk factor distributionInforming public health policyPublic health policiesPublic health communityRisk factor effectsHousehold risk factorsDiarrhoeal disease burdenFactor effect estimatesHealth policyDiarrhoeal disease surveillanceEcuadorian villageNational policy decisionsHealth communityDisease burdenCross-sectionDisease surveillanceFactor distributionRiskGeographic regions